Research & Development

色大姐综合网亚洲天堂a2018无码隔壁老王aⅴ无码天堂2018在线保罗隐蔽动作击打英格拉姆! 这球他还喊冤?


  劉徹站著的時候,別人就要跪著。   特制的圓桌上杯盤狼藉,甚至還有酒。色大姐综合网   “夫天地者,萬物之逆旅;光陰者,百代之過客。而浮生若夢,為歡幾何?”亚洲天堂a2018无码隔壁老王   雲瑯很不願意跟霍去病,曹襄,李敢這些人談論男女之事,在他們眼中,女人除過有傳宗接代的作用之外,就是玩物。 aⅴ无码天堂2018在线   “有《美人歌》作證,君侯恐怕很難把自己洗干淨,更何況,劉陵在某些時候還是陛下的女人,這樣的事情傳出去,對您極為不利……”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo